Reuters Health Report

Click to View in Browser 12/24/2013 Settlement reached over deadly U.S. meningitis outbreak (Reuters) - Owners and insurers of a now-bankrupt Massachusetts pharmacy linked to a deadly meningitis outbreak have agreed to pay more than $100 million to compensate victims, families of victims and creditors. FDA rejects Actavis' contraceptive patch, seeks more data (Reuters) - Actavis Plc said U.S. health regulators denied approval to its contraceptive patch for women and asked for more data. Obamacare signup deadline pushed back to Tuesday WASHINGTON (Reuters) - As Americans scrambled to beat a deadline to sign up for insurance under President Barack Obama's healthcare law, the White House gave most consumers an extra day, until Tuesday, to obtain coverage that starts January 1. U.S. FDA approves Novo Nordisk's drug for rare blood clotting disorder (Reuters) - The U.S. Food and Drug Administration said on Monday it has approved Novo Nordisk's drug Tretten to prevent bleeding in patients with a rare blood clotting disorder. Lactation consultants can boost breastfeeding NEW YORK (Reuters Health) - Having access to even a few hours with a professional specially trained to help women breastfeed may raise the number of women who start breastfeeding and stick with it, according to a new study. Assess BRCA risk in women with family history: panel NEW YORK (Reuters Health) - Women with a family history of breast or ovarian cancer should be assessed to see if those cancers could be linked to certain mutations, according to new recommendations. Is it safe for pregnant women to eat peanuts? NEW YORK (Reuters Health) - So long as they don't have nut allergies themselves, pregnant women shouldn't be afraid that eating nuts might trigger allergies in their child, according to a large new study. Early start to weight gain tied to later heart risks NEW YORK (Reuters Health) - Kids who start rapidly gaining weight early in childhood are more likely to have higher blood pressure and other signs of future heart trouble as preteens, a new study suggests. Weak nausea drug data knocks back Tesaro shares (Reuters) - Tesaro Inc's experimental drug for treating chemotherapy-induced nausea and vomiting (CINV) failed to show enough benefit in trials to give it an edge over competing drugs, sending its shares down as much as 24 percent. China investigates after vaccine suspected in seven deaths BEIJING (Reuters) - Chinese health authorities are investigating after seven infants died following inoculation with a hepatitis B vaccine, state media reported on Monday. Related Video Future repellents mess with mosquito's mind Rudolph's adaptive eyes could pose Christmas problems The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend